NCT02679742 (PSSMAR) is a NA clinical trial of β-hydroxymethylbutyrate in Sarcopenia, sponsored by Parc de Salut Mar.

Who is sponsoring NCT02679742?

NCT02679742 is sponsored by Parc de Salut Mar.

What drugs are being tested in NCT02679742?

Interventions in NCT02679742: β-hydroxymethylbutyrate, Placebo.

What condition does NCT02679742 study?

NCT02679742 studies Sarcopenia.

Is NCT02679742 still recruiting?

NCT02679742 is currently completed. Last updated 10 February 2021.

Last reviewed 2021-02-10 · How we verify

NCT02679742: PSSMAR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Postacute Sarcopenia: Supplementation With β-hydroxyMethylbutyrate After Resistance Training

Completed NA Last updated 10 February 2021

What this trial tests

NA trial testing β-hydroxymethylbutyrate in Sarcopenia in 32 participants. Completed in 6 February 2021.

Timeline

1 March 2017

Primary endpoint
6 February 2021

6 February 2021

Quick facts

Lead sponsor	Parc de Salut Mar
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	32
Start date	1 March 2017
Primary completion	6 February 2021
Estimated completion	6 February 2021
Sites	1 location across Spain

Drugs / interventions tested

β-hydroxymethylbutyrate
Placebo

Conditions studied

Sarcopenia — all drugs for Sarcopenia →

Sponsor

Parc de Salut Mar — full company profile →

Who can join

60 and older, any sex, with Sarcopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized, double-blind, placebo-controlled, parallel study to assess the effects of β-hydroxymethylbutyrate (β-HMB) combined with a resistance training program, after an acute process in older patients with sarcopenia in terms of muscle mass, muscle strength and physical performance. Treatments compared will be β-hydroxymethylbutyrate (β-HMB) with a resistance training program or placebo with a resistance training program.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Protein Intake Recommendation for Korean Older Adults to Prevent Sarcopenia: Expert Consensus by the Korean Geriatric Society and the Korean Nutrition Society.
Jung HW, Kim SW, Kim IY, Lim JY, et al · · 2018 · cited 30× · PMID 32743269 · DOI 10.4235/agmr.18.0046
Resistance Training and Nutritional Supplementation in Older Adults with Sarcopenia after Acute Disease: A Feasibility Study.
Meza-Valderrama D, Sánchez-Rodríguez D, Peña YC, Ramírez-Fuentes C, et al · · 2024 · cited 5× · PMID 39339653 · DOI 10.3390/nu16183053

Verify or expand the search:

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting
NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting

Other Parc de Salut Mar trials

Trials by the same sponsor.

NCT06163235 — Efficacy of a Mobile Application and Semi-attendance Program in Bariatric Surgery · NA · not yet recruiting
NCT07223450 — A Study on Oral and Intranasal Forms of Oxycodone in Healthy Volunteers Using Pharmacokinetic Modeling · Phase 1 · completed
NCT07504913 — Spanish Validation of KOQUSS-40 Questionnaire: Assessing QoL of Gastric Cancer Patients After Gastrectomy: SPQUSS-41 · recruiting
NCT06806072 — BALNEOTHERAPY FOR BREAST CANCER PATIENTS UNDERGOING ENDOCRINE THERAPY · NA · not yet recruiting
NCT04084795 — Augmentation of EMDR With tDCS in the Treatment of Fibromyalgia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02679742 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Parc de Salut Mar
Last refreshed: 10 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02679742.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing